Building Strong and Mutually Rewarding Partnerships

Together with our global partners, we are committed towards working with world-renowned medical, academic and research institutions in the Life Sciences and Healthcare industries, to enhance diagnosis, research and therapeutics. Each partner has at least one Genesis®200 or Laennec® onsite, with some of them integrating complementary modalities - like multiplexing and Next-Generation Sequencing (NGS) - with our technology to pursue their academic and commercial research.

Currently, about 120 hospitals, universities, research institutes, contract research organisations and pharmaceutical companies all over the world have benefited from our imaging solutions. If you would like to see advances in your preclinical and clinical research needs, we'd love to meet you! 

Together, we can foster mutual goals and objectives towards better patient outcomes.